Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Raymond James Downgrades First Commonwealth to Market Perform

Raymond James Downgrades First Commonwealth to Market Perform

Raymond James analyst David Feaster downgrades First Commonwealth (NYSE:FCF) from Outperform to Market Perform.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Raymond James analyst David Feaster downgrades First Commonwealth (NYSE:FCF) from Outperform to Market Perform.

Analyst Ratings

What Analysts Are Saying About PBF Energy Stock

By Benzinga Insights

January 3, 9:00 AM

In the latest quarter, 4 analysts provided ratings for PBF Energy (NYSE:PBF), showcasing a mix of bullish and…

PBF

Oxford Industries Q3 Adj. EPS $1.46 Beats $1.22 Estimate, Sales $313.03M Beat $303.37M Estimate

By Michael Horton

December 7, 5:09 PM

Oxford Industries (NYSE:OXM) reported quarterly earnings of $1.46 per share which beat the analyst consensus estimate of $1.22 by 19.67 percent. This is a 22.69 percent increase over earnings of $1.19 per share from the

OXM

Stifel Maintains Buy on Masimo, Raises Price Target to $172

By Benzinga Newsdesk

September 12, 9:59 AM

Stifel analyst Rick Wise maintains Masimo (NASDAQ:MASI) with a Buy and raises the price target from $162 to $172.

MASI

News

Novo Nordisk Announced Earlier, It Will Invest More Than 42B Danish Kroner In Expansion Of Manufacturing Facilities In Kalundborg, Denmark

By Charles Gross

November 10, 5:52 AM

Novo Nordisk today announced plans to invest more than 42 billion Danish kroner starting in 20231 to expand existing manufacturing facilities in Kalundborg, Denmark, for the current and future product portfolio within

NVO

Raymond James Downgrades First Commonwealth to Market Perform

Related Posts

What Analysts Are Saying About PBF Energy Stock

Oxford Industries Q3 Adj. EPS $1.46 Beats $1.22 Estimate, Sales $313.03M Beat $303.37M Estimate

Stifel Maintains Buy on Masimo, Raises Price Target to $172

Novo Nordisk Announced Earlier, It Will Invest More Than 42B Danish Kroner In Expansion Of Manufacturing Facilities In Kalundborg, Denmark